T80.82XA — Complication of immune effector cellular therapy, initial encounter
T80.82XA is a billable, specific ICD-10-CM code for complication of immune effector cellular therapy, initial encounter. It is valid for submission on a claim.
7th character "A" — initial encounter
The appropriate 7th character is to be added to each code from category T80
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Excludes2 — not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
Use additional code
Add a secondary code to capture the detail described below.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Complication of chimeric antigen receptor (CAR-T) cell therapy
- Complication of IEC therapy
Risk adjustment
T80.82XA does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
T80.82XA is named in 2 Medicare coverage policies — 2 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A59105Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
- A60187Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
Related codes at this level
Codes that share T80.82. If T80.82XA is not quite right, the correct code is usually one of these.
Questions about T80.82XA
- Is T80.82XA a billable ICD-10-CM code?
- Yes. T80.82XA is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does T80.82XA sit in the tabular list?
- Injury, poisoning and certain other consequences of external causes (S00-T88), in the block Complications of surgical and medical care, not elsewhere classified (T80-T88).